EP Biocomposites Ltd Financials
Company Logo

EP Biocomposites Ltd Financial Statement

EP Biocomposites Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

EP Biocomposites Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual11.44
Operating Expenses Annual10.03
Operating Profit Annual1.71
Interest Annual0.03
Depreciation0.10
Net Profit Annual1.15
Tax Annual0.42

EP Biocomposites Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.19
Cash Flow from Operations-1.24
Cash Flow from Investing-0.16
Cash Flow from Financing0.49
Cash Flow at the End1.27

EP Biocomposites Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)14.95
PBIT Margin (%)14.07
PBT Margin (%)-337.77
Net PROFIT Margin (%)10.05
Return On Networth / Equity (%)12.80
Return On Networth /Employed (%)15.28
Return On Assets (%)10.86
Total Debt / Equity (X)0.17
Asset Turnover Ratio (%)1.08

EP Biocomposites Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.33
Total Current Assets Annual12.49
Non Current Assets Annual2.58
Total Shareholders Funds Annual9.56
Total Assets Annual15.07

EP Biocomposites Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 20, 2024, EP Biocomposites Ltd has a market capitalization of 23.06 Cr. Value Research classifies it as a Micro-Cap company.
Yes, EP Biocomposites Ltd is debt-free with a debt-to-equity ratio of 0.19.
In FY 2023 , EP Biocomposites Ltd recorded a total revenue of approximately 11.44 Cr marking a significant milestone in the company's financial performance.
EP Biocomposites Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..
EP Biocomposites Ltd's current PE ratio is 20.05.
EP Biocomposites Ltd's ROCE averaged 15.4% from the FY ending March 2022 to 2024, with a median of 14.1%. It peaked at 21.6% in March 2022, reflecting strong capital efficiency over the period..
EP Biocomposites Ltd's latest EBIT is Rs. 1.60 Cr, surpassing the average EBIT of Rs. 1.31 Cr over the 5 years..